Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-30 17:45:27 - browse：45

Closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. — A brain affected by Alzheimer's disease, at the Museum of Neuroanatomy at the University at Buffalo. David Duprey/AP

Investigators on Wednesday released the first detailed case report about a patient who died after receiving lecanemab, providing a new glimpse into safety concerns surrounding the closely watched experimental Alzheimer’s drug.

An unpublished version of the report was previously written about by Science in November, one of three deaths from the lecanemab trials revealed by Science and STAT. But the published version, in the New England Journal of Medicine, will allow doctors to evaluate the case as they consider whether and how to use a treatment that could be approved by the FDA as soon as this week.

This “will have greater impact on clinicians because it is peer-reviewed and published in the New England Journal,” said Lon Schneider, an Alzheimer’s expert at University of Southern California, who was not affiliated with the work.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Readout LOUD podcast: Live from STAT Breakthrough Summit West

knowledge

hotspot

WSS

Health Care Service Corp to buy Cigna Medicare Advantage plans

Glen Campbell's doctor discusses his public struggle with Alzheimer's

FTC sues over Novant Health acquisition of two N.C. hospitals

New clues to why women have higher risk of autoimmune disorders

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Reconstructing family trees of blood cells may help predict disease

Wikipedia

Wikipedia

entertainment

Novavax promises a turnaround & Lilly roils the obesity market

Addiction experts warn against a second 'war on drugs'

After affirmative action ruling, medical educators look to 'holistic review'

Readers respond to H5N1 and livestock movements, and more

Medical leaders decry Supreme Court decision on affirmative action

10 reasons why health care startups fail

Activists slam private health insurers over coverage restrictions

New clues to why women have higher risk of autoimmune disorders

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Cytokinetics CEO stresses company can launch heart drug on its own

leisure time

Helping hospitals and community health centers plan for resilience

Vertex non

Merck, Johnson & Johnson CEOs will testify on high drug prices

Syphilis numbers in the United States reach record heights

Wegovy leads to weight loss. Can it treat depression, too?

Readout Newsletter: The latest on Novavax, Merck, Bluebird

knowledge

focus

hotspot

knowledge